BIOLARGO, INC.: director Bray Christina Elaine received 234,375 shares

What happened

• The filing says Bray Christina Elaine, a director, was granted an option to acquire 234,375 shares on Sep 30, 2026.
• The filing lists the transaction as a derivative award with the acquisition price shown as N/A and notes the option was issued as payment of $18,750 in fees under the issuer's 2024 Equity Incentive Plan; the number of shares equals the fees divided by the exercise price.

Key details

• Transaction date: Sep 30, 2026; transaction type: grant/award (code A); shares: 234,375; price: N/A (derivative).
• Filing date: Oct 2, 2026.
• Shares owned after the transaction: not reported in the supplied filing.
• Footnote F1: the option was issued to the reporting person as payment for $18,750 in fees for board services, pursuant to the issuer's 2024 Equity Incentive Plan; the share count is calculated by dividing the fees by the option's exercise price.

Why it may matter

• This filing documents an option grant (a derivative award), not an open-market purchase or sale.
• A filing does not show why the insider traded or why the company acted.